A novel pMEK inhibitor ABM-4095 for the treatment of pancreatic cancerCANCER RESEARCHIF16.62024-03-220PRE
Studies on pMEK inhibitors for the treatment of RAS-mutant cancers as a single agent or combinationsCANCER RESEARCHIF16.62024-03-220PRE
Preclinical development of ABM-168, a novel MEK Inhibitor to treat cancer with brain tumorsCANCER RESEARCHIF16.62023-04-043PRE
A potent and selective CDK8 inhibitor ABM-3249 with excellent efficacies in multiple in vivo cancer modelsCANCER RESEARCHIF16.62023-04-041PRE
ABM-1310 has significant improved BBB-penetration and intracranial tumor growth inhibition compared to FDA approved BRAF inhibitorsCANCER RESEARCHIF16.62023-04-040PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项